Acutus Medical, Inc. (NASDAQ:AFIB) Q4 2022 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to Acutus Medical's Fourth Quarter and Full Year 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Acutus Medical Inc. (AFIB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 2,651,667 | $3,049,417 | 0.06% | |
| 2. | OrbiMed Advisors Samuel Isaly | 2,648,386 | $3,045,644 | 0.05% | |
| 3. | Kamunting Street Capital Allan Teh | 259,437 | $298,350 | -55% | 0.47% |
| 4. | Parkman Healthcare Partners Greg Martinez | 52,027 | $59,831 | 0.01% | |
| 5. | Citadel Investment Group Ken Griffin | 28,435 | $32,700 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.78 | 40,000 | Director | 52,911 | 2021-11-15 | Filing | |
| $14.00 | 357,143 | Large Shareholder, Director | 1,677,361 | 2021-07-19 | Filing | |
| $14.00 | 714,285 | Large Shareholder, Director | 4,872,025 | 2021-07-19 | Filing | |
| $14.00 | 357,143 | Large Shareholder, Director | 1,677,361 | 2021-07-19 | Filing | |
| $14.00 | 714,285 | Large Shareholder, Director | 4,872,025 | 2021-07-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.58 | 60,000 | Director | 507,509 | 2022-06-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,140,706 | $1,311,812 | 0% | |
| 2. | 797,523 | $917,151 | 0% | |
| 3. | 226,501 | $260,476 | 0% | |
| 4. | 127,877 | $147,059 | 0% | |
| 5. | 79,500 | $91,425 | 0% |
News See All
Is It Too Late to Buy Acutus Medical (AFIB) Stock?
Baron Discovery Fund recently published its first-quarter commentary – a copy of which can be downloaded here.
Is AFIB A Good Stock To Buy Now?
In this article we will check out the progression of hedge fund sentiment towards Acutus Medical, Inc. (NASDAQ:AFIB) and determine whether it is a good investment right now.
Is Acutus Medical (AFIB) a Smart Long-term Buy?
Baron Discovery Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Billionaire Hedge Funds
